Increased DNA damage and increased PARP activity were shown in PBMCs in correlation with COPD severity, indicating that intensified DNA repair occurs in the PBMCs of patients with higher COPD stages [2]. This evidence concerns the gene PARP1 and chronic obstructive pulmonary disease.